People news: Par Pharmaceutical

Share this article:
Par Pharmaceutical Companies said John MacPhee had resigned as president of Strativa Pharmaceuticals and EVP Par Pharmaceutical “to pursue other interests” after six years with the company. Day-to-day oversight of Strativa, the company's proprietary products division, will be assumed by Par chairman, president and CEO Patrick LePore on an interim basis. Woodcliff Lake, NJ-based Par's focus is on marketing higher-barrier-to-entry generics and niche, innovative branded drugs.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters